Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Articles published by Bayer

< Previous 1 2 3 4 5 6 7 8 9 Next >

FDA Label Update Reflects Bayer’s Commitment to Providing Options for Long-acting Contraception

August 18, 2022

From Bayer

Via Business Wire

Bayer Launches ForGround, a Unique Sustainable Agriculture Platform Focused on Transforming How Farmers and Companies Collaborate

August 15, 2022

From Bayer

Via Business Wire

U.S. FDA Approves Additional Indication of NUBEQA® (darolutamide) in Combination with Docetaxel for the Treatment of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

August 05, 2022

From Bayer

Via Business Wire

Stem & Root Daily Immunity Named Immune Support “Product of the Year” at NutraIngredients-USA Annual Industry Awards

July 26, 2022

From Bayer

Via Business Wire

Bayer Earns Top Score on 2022 Disability Equality Index

July 21, 2022

From Bayer

Via Business Wire

Astepro® Allergy, First and Only Steroid-Free Antihistamine Nasal Spray Now Available Over-the-Counter

July 12, 2022

From Bayer

Via Business Wire

Bayer Opens New Research & Innovation Center in Boston-Cambridge Demonstrating Its Commitment to Precision Oncology

June 29, 2022

From Bayer

Via Business Wire

Bayer’s KERENDIA® (finerenone) Receives New Recommendations From American Diabetes Association for Improving Cardiovascular Outcomes and Managing Patients With Chronic Kidney Disease Associated With Type 2 Diabetes

June 28, 2022

From Bayer

Via Business Wire

Alka-Seltzer® Launches New Hangover Relief Product in a Musical Collaboration with T-Pain

June 28, 2022

From Bayer

Via Business Wire

Bayer Launches Calantic™ Digital Solutions to help Address Radiology Industry Challenges

June 28, 2022

From Bayer

Via Business Wire

Midol® Encourages Menstruators to Find Comfort in Speaking Up and Acknowledging ‘The Real Reason’ Behind Changing Plans When Period Symptoms Strike

June 23, 2022

From Bayer

Via Business Wire

Bayer and Luke Bryan Continue Partnership to Celebrate America’s Farmers and Fight Hunger with #HeresToTheFarmer Campaign

June 17, 2022

From Bayer

Via Business Wire

Bayer’s Vividion Emerging as Significant Player in San Diego Biotech Hub

June 09, 2022

From Bayer

Via Business Wire

Bayer Appoints Two New Members to U.S. Country Leadership Team

June 01, 2022

From Bayer

Via Business Wire

Bayer to Present Key Data Across Oncology Portfolio Showcasing Significant Advances in Cancer Care at 2022 ASCO Annual Meeting

May 19, 2022

From Bayer

Via Business Wire

U.S. FDA Accepts Supplemental New Drug Application (sNDA) and Grants Priority Review for NUBEQA® (darolutamide) in Combination with Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

May 03, 2022

From Bayer

Via Business Wire

Claritin® Teams Up with Nate Berkus and Jeremiah Brent to Inspire Families to Spend More Time Outside and Embrace their Outdoor Space

April 26, 2022

From Bayer

Via Business Wire

Bayer to Create Ag Biologicals Powerhouse Partnership with Ginkgo Bioworks, Advancing Joyn Bio Technology Platforms

April 22, 2022

From Bayer

Via Business Wire

Bayer Presents New Subgroup Analyses for KERENDIA® (finerenone) for Chronic Kidney Disease Associated With Type 2 Diabetes With or Without History of Atherosclerotic Cardiovascular Disease

April 04, 2022

From Bayer

Via Business Wire

Bayer Set to Drive Breakthrough Innovations in the Life Sciences

April 01, 2022

From Bayer

Via Business Wire

Bayer to Highlight New Cardiovascular and Renal Data at ACC.22, Including Late-Breaking Presentations for KERENDIA® (finerenone) as Well as Oral Factor XIa Inhibitor (asundexian) Program

March 29, 2022

From Bayer

Via Business Wire

Stem and Root and Nutrileads Announce Launch of Daily Immunity for Optimized Immune Function Powered by BeniCaros for Ground Breaking Immunity Support

March 15, 2022

From Bayer

Via Business Wire

Positive Results from Phase III Investigational Trial Shows NUBEQA® (darolutamide) Plus Androgen Deprivation Therapy (ADT) and Docetaxel Significantly Increases Overall Survival (OS) in Patients with mHSPC

February 17, 2022

From Bayer

Via Business Wire

Bayer Highlights Advancements of Agriculture Industry’s Most Prolific R&D Pipeline

February 16, 2022

From Bayer

Via Business Wire

Bayer Receives FDA Fast Track Designation for asundexian Stroke Program

February 10, 2022

From Bayer

Via Business Wire

Bayer Earns Top Score in 2022 Corporate Equality Index for Fifth Consecutive Year

January 27, 2022

From Bayer

Via Business Wire

Bayer to Launch Project Carbonview, an Industry-First Digital Carbon Footprint Measurement Solution for Agriculture

December 08, 2021

From Bayer

Via Business Wire

Phase III Investigational Trial of NUBEQA® (darolutamide) in Combination with Docetaxel and Androgen Deprivation Therapy (ADT) Meets Primary Endpoint of Significantly Increasing Overall Survival (OS) in Patients with mHSPC

December 03, 2021

From Bayer

Via Business Wire

Bayer Invests €100 million in Sustainable Health Products to Advance Company’s 2030 Sustainability Commitments

December 01, 2021

From Bayer

Via Business Wire

Bayer Wins U.S. Chamber of Commerce Foundation’s Annual Citizens Award

November 18, 2021

From Bayer

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.